2026-2030年全球胜肽合成市场

全球胜肽合成市场预计将从 2025 年到 2030 年成长至 5.456 亿美元，预测期内复合年增长率为 8.7%。

本报告对全球胜肽合成市场进行了全面分析，包括市场规模和预测、趋势、成长要素、挑战以及涵盖约 25 家供应商的供应商分析。

本报告对当前市场状况、最新趋势和驱动因素以及整体市场环境进行了最新分析。推动市场发展的因素包括：口服给药系统的产业化和生物利用度的优化、人工智慧驱动的电脑辅助In Silico药物发现的战略主流化、CDMO（合约开发和生产）能力的结构性扩展以及自动化固相合成。

本研究客观地结合了一手和二手讯息，包括来自主要行业相关人员的信息。报告内容涵盖主要企业分析、全面的市场规模数据、区域細項分析以及供应商格局。报告同时呈现历史数据和预测数据。

本研究指出，自动化连续流合成和高通量组装技术的融合将是未来几年全球胜肽合成市场成长的关键驱动因素。此外，绿色化学的需求、永续溶剂回收系统的普及以及个人化新抗原和精准肿瘤肽疗法的拓展，预计将带来显着的市场需求。

目录

第一章执行摘要

第二章 Technavio 分析

• 分析定价、生命週期、顾客购买篮子、采用率和购买标准。
• 输入的重要性及差异化因素
• 混淆因素
• 促进因素和挑战的影响

第三章 市场状况

• 市场生态系统
• 市场特征
• 价值链分析

第四章 市场规模

• 市场的定义
• 市场区隔分析
• 2025年市场规模
• 2025-2030年市场展望

第五章 市场规模与表现

• 2020-2024年全球胜肽合成市场
• 2020-2024年产品细分市场分析
• 2020-2024年技术细分市场分析
• 2020-2024年按应用领域分類的细分市场分析
• 2020-2024年区域市场分析
• 2020-2024年各国细分市场分析

第六章 定性分析

• 人工智慧的影响：全球胜肽合成市场
• 地缘政治衝突影响全球胜肽合成市场。

第七章：五力分析

• 五力模型概述
• 买方的议价能力
• 供应商的议价能力
• 新进入者的威胁
• 替代品的威胁
• 竞争威胁
• 市场状况

第八章 市场区隔：依产品

• 比较：按产品
• 消耗品
• 装置
• 服务
• 市场机会：依产品划分

第九章 市场区隔：依技术划分

• 比较：按技术
• 化学
• 生物
• 市场机会：依技术划分

第十章 市场区隔：依应用

• 比较：按应用
• 治疗用途
• 诊断
• 研究
• 市场机会：依应用领域划分

第十一章 客户情况

第十二章 区域情势

• 区域划分
• 区域比较
• 北美洲
  • 我们
  • 加拿大
  • 墨西哥
• 欧洲
  • 德国
  • 英国
  • 法国
  • 义大利
  • 西班牙
  • 瑞士
• 亚洲
  • 印度
  • 中国
  • 日本
  • 韩国
  • 新加坡
  • 印尼
• 世界其他地区
  • 巴西
  • 南非
  • 阿拉伯聯合大公国
  • 沙乌地阿拉伯
  • 阿根廷
  • 以色列
  • 土耳其
  • 智利
• 市场机会：按地区划分

第十三章 促进因素、挑战与机会

• 市场驱动因素
• 市场挑战
• 促进因素和挑战的影响
• 市场机会

第十四章 竞争格局

• 概述
• 竞争格局
• 混乱局面
• 产业风险

第十五章 竞争分析

• 公司简介
• 公司排名指标
• 企业市场定位
• Agilent Technologies Inc.
• AmbioPharm Inc.
• AnaSpec Inc.
• Bio Synthesis Inc
• Biomatik Corp.
• CEM Corp.
• ChinaPeptides Co. Ltd.
• Corden Pharma Intl. GmbH
• GenScript Biotech Corp.
• JPT Peptide Technologies GmbH
• PolyPeptide Group
• Proteo Genix
• RS Synthesis
• Sigma Aldrich Chemicals Ltd.
• Thermo Fisher Scientific Inc.

第十六章附录

The global peptide synthesis market is forecasted to grow by USD 545.6 mn during 2025-2030, accelerating at a CAGR of 8.7% during the forecast period. The report on the global peptide synthesis market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by industrialization of oral delivery systems and bioavailability optimization, strategic mainstreaming of ai-enhanced in-silico peptide discovery, structural expansion of cdmo capacity and automated solid-phase synthesis.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Technavio's global peptide synthesis market is segmented as below:

By Product

• Consumables
• Equipment
• Services

By Technique

• Chemical
• Biological

By Application

• Therapeutic
• Diagnostic
• Research

Geography

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Switzerland
• Asia
• Rest of World (ROW)
• Rest of World (ROW)

This study identifies the integration of automated continuous flow synthesis and high-throughput assembly as one of the prime reasons driving the global peptide synthesis market growth during the next few years. Also, growth of green chemistry mandates and sustainable solvent recovery architectures and proliferation of personalized neoantigen and precision oncology peptide modalities will lead to sizable demand in the market.

The report on the global peptide synthesis market covers the following areas:

• Global peptide synthesis market sizing
• Global peptide synthesis market forecast
• Global peptide synthesis market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading global peptide synthesis market vendors that include Agilent Technologies Inc., AmbioPharm Inc., AnaSpec Inc., Bachem AG, Bio Synthesis Inc, Biomatik Corp., Biosynth Ltd., CEM Corp., ChinaPeptides Co. Ltd., Corden Pharma Intl. GmbH, CPC Scientific Inc., GenScript Biotech Corp., GL Biochem, JPT Peptide Technologies GmbH, LifeTein LLC., PolyPeptide Group, Proteo Genix, RS Synthesis, Sigma Aldrich Chemicals Ltd., Thermo Fisher Scientific Inc.. Also, the global peptide synthesis market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
  • Executive Summary - Chart on Market Overview
  • Executive Summary - Data Table on Market Overview
  • Executive Summary - Chart on Global Market Characteristics
  • Executive Summary - Chart on Market by Geography
  • Executive Summary - Chart on Market Segmentation by Product
  • Executive Summary - Chart on Market Segmentation by Technique
  • Executive Summary - Chart on Market Segmentation by Application
  • Executive Summary - Chart on Incremental Growth
  • Executive Summary - Data Table on Incremental Growth
  • Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

• 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 2.2 Criticality of inputs and Factors of differentiation
• 2.3 Factors of disruption
• 2.4 Impact of drivers and challenges

3 Market Landscape

• 3.1 Market ecosystem
• 3.2 Market characteristics
• 3.3 Value chain analysis

4 Market Sizing

• 4.1 Market definition
• 4.2 Market segment analysis
  • Market segments
• 4.3 Market size 2025
• 4.4 Market outlook: Forecast for 2025-2030

5 Historic Market Size

• 5.1 Global Peptide Synthesis Market 2020 - 2024
  • Historic Market Size - Data Table on Global Peptide Synthesis Market 2020 - 2024 ($ million)
• 5.2 Product segment analysis 2020 - 2024
  • Historic Market Size - Product Segment 2020 - 2024 ($ million)
• 5.3 Technique segment analysis 2020 - 2024
  • Historic Market Size - Technique Segment 2020 - 2024 ($ million)
• 5.4 Application segment analysis 2020 - 2024
  • Historic Market Size - Application Segment 2020 - 2024 ($ million)
• 5.5 Geography segment analysis 2020 - 2024
  • Historic Market Size - Geography Segment 2020 - 2024 ($ million)
• 5.6 Country segment analysis 2020 - 2024
  • Historic Market Size - Country Segment 2020 - 2024 ($ million)

6 Qualitative Analysis

• 6.1 Impact of AI in global peptide synthesis market
• 6.2 Impact of geopolitical conflict for global peptide synthesis market

7 Five Forces Analysis

• 7.1 Five forces summary
  • Five forces analysis - Comparison between 2025 and 2030
• 7.2 Bargaining power of buyers
  • Bargaining power of buyers - Impact of key factors 2025 and 2030
• 7.3 Bargaining power of suppliers
  • Bargaining power of suppliers - Impact of key factors in 2025 and 2030
• 7.4 Threat of new entrants
  • Threat of new entrants - Impact of key factors in 2025 and 2030
• 7.5 Threat of substitutes
  • Threat of substitutes - Impact of key factors in 2025 and 2030
• 7.6 Threat of rivalry
  • Threat of rivalry - Impact of key factors in 2025 and 2030
• 7.7 Market condition

8 Market Segmentation by Product

• 8.1 Market segments
• 8.2 Comparison by Product
• 8.3 Consumables - Market size and forecast 2025-2030
• 8.4 Equipment - Market size and forecast 2025-2030
• 8.5 Services - Market size and forecast 2025-2030
• 8.6 Market opportunity by Product
  • Market opportunity by Product ($ million)

9 Market Segmentation by Technique

• 9.1 Market segments
• 9.2 Comparison by Technique
• 9.3 Chemical - Market size and forecast 2025-2030
• 9.4 Biological - Market size and forecast 2025-2030
• 9.5 Market opportunity by Technique
  • Market opportunity by Technique ($ million)

10 Market Segmentation by Application

• 10.1 Market segments
• 10.2 Comparison by Application
• 10.3 Therapeutic - Market size and forecast 2025-2030
• 10.4 Diagnostic - Market size and forecast 2025-2030
• 10.5 Research - Market size and forecast 2025-2030
• 10.6 Market opportunity by Application
  • Market opportunity by Application ($ million)

11 Customer Landscape

• 11.1 Customer landscape overview
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

12 Geographic Landscape

• 12.1 Geographic segmentation
• 12.2 Geographic comparison
• 12.3 North America - Market size and forecast 2025-2030
  • 12.3.1 US - Market size and forecast 2025-2030
  • 12.3.2 Canada - Market size and forecast 2025-2030
  • 12.3.3 Mexico - Market size and forecast 2025-2030
• 12.4 Europe - Market size and forecast 2025-2030
  • 12.4.1 Germany - Market size and forecast 2025-2030
  • 12.4.2 UK - Market size and forecast 2025-2030
  • 12.4.3 France - Market size and forecast 2025-2030
  • 12.4.4 Italy - Market size and forecast 2025-2030
  • 12.4.5 Spain - Market size and forecast 2025-2030
  • 12.4.6 Switzerland - Market size and forecast 2025-2030
• 12.5 Asia - Market size and forecast 2025-2030
  • 12.5.1 India - Market size and forecast 2025-2030
  • 12.5.2 China - Market size and forecast 2025-2030
  • 12.5.3 Japan - Market size and forecast 2025-2030
  • 12.5.4 South Korea - Market size and forecast 2025-2030
  • 12.5.5 Singapore - Market size and forecast 2025-2030
  • 12.5.6 Indonesia - Market size and forecast 2025-2030
• 12.6 Rest of World (ROW) - Market size and forecast 2025-2030
  • 12.6.1 Brazil - Market size and forecast 2025-2030
  • 12.6.2 South Africa - Market size and forecast 2025-2030
  • 12.6.3 UAE - Market size and forecast 2025-2030
  • 12.6.4 Saudi Arabia - Market size and forecast 2025-2030
  • 12.6.5 Argentina - Market size and forecast 2025-2030
  • 12.6.6 Israel - Market size and forecast 2025-2030
  • 12.6.7 Turkey - Market size and forecast 2025-2030
  • 12.6.8 Chile - Market size and forecast 2025-2030
• 12.7 Market opportunity by geography
  • Market opportunity by geography ($ million)
  • Data Tables on Market opportunity by geography ($ million)

13 Drivers, Challenges, and Opportunity

• 13.1 Market drivers
  • Industrialization of oral delivery systems and bioavailability optimization
  • Strategic mainstreaming of AI-enhanced in-silico peptide discovery
  • Structural expansion of CDMO capacity and automated solid-phase synthesis
• 13.2 Market challenges
  • Intensification of environmental sustainability mandates and solvent waste management
  • Persistence of manufacturing scalability constraints and structural capacity bottlenecks
  • Technical debt of achieving purity standards and specialized labor scarcity
• 13.3 Impact of drivers and challenges
  • Impact of drivers and challenges in 2025 and 2030
• 13.4 Market opportunities
  • Integration of automated continuous flow synthesis and high-throughput assembly
  • Growth of green chemistry mandates and sustainable solvent recovery architectures
  • Proliferation of personalized neoantigen and precision oncology peptide modalities

14 Competitive Landscape

• 14.1 Overview
• 14.2 Competitive Landscape
  • Overview on criticality of inputs and factors of differentiation
• 14.3 Landscape disruption
  • Overview on factors of disruption
• 14.4 Industry risks
  • Impact of key risks on business

15 Competitive Analysis

• 15.1 Companies profiled
  • Companies covered
• 15.2 Company ranking index
  • Company ranking index
• 15.3 Market positioning of companies
  • Matrix on companies position and classification
• 15.4 Agilent Technologies Inc.
  • Agilent Technologies Inc. - Overview
  • Agilent Technologies Inc. - Business segments
  • Agilent Technologies Inc. - Key news
  • Agilent Technologies Inc. - Key offerings
  • Agilent Technologies Inc. - Segment focus
  • SWOT
• 15.5 AmbioPharm Inc.
  • AmbioPharm Inc. - Overview
  • AmbioPharm Inc. - Product / Service
  • AmbioPharm Inc. - Key offerings
  • SWOT
• 15.6 AnaSpec Inc.
  • AnaSpec Inc. - Overview
  • AnaSpec Inc. - Product / Service
  • AnaSpec Inc. - Key offerings
  • SWOT
• 15.7 Bio Synthesis Inc
  • Bio Synthesis Inc - Overview
  • Bio Synthesis Inc - Product / Service
  • Bio Synthesis Inc - Key offerings
  • SWOT
• 15.8 Biomatik Corp.
  • Biomatik Corp. - Overview
  • Biomatik Corp. - Product / Service
  • Biomatik Corp. - Key offerings
  • SWOT
• 15.9 CEM Corp.
  • CEM Corp. - Overview
  • CEM Corp. - Product / Service
  • CEM Corp. - Key offerings
  • SWOT
• 15.10 ChinaPeptides Co. Ltd.
  • ChinaPeptides Co. Ltd. - Overview
  • ChinaPeptides Co. Ltd. - Product / Service
  • ChinaPeptides Co. Ltd. - Key offerings
  • SWOT
• 15.11 Corden Pharma Intl. GmbH
  • Corden Pharma Intl. GmbH - Overview
  • Corden Pharma Intl. GmbH - Product / Service
  • Corden Pharma Intl. GmbH - Key offerings
  • SWOT
• 15.12 GenScript Biotech Corp.
  • GenScript Biotech Corp. - Overview
  • GenScript Biotech Corp. - Business segments
  • GenScript Biotech Corp. - Key offerings
  • GenScript Biotech Corp. - Segment focus
  • SWOT
• 15.13 JPT Peptide Technologies GmbH
  • JPT Peptide Technologies GmbH - Overview
  • JPT Peptide Technologies GmbH - Product / Service
  • JPT Peptide Technologies GmbH - Key offerings
  • SWOT
• 15.14 PolyPeptide Group
  • PolyPeptide Group - Overview
  • PolyPeptide Group - Product / Service
  • PolyPeptide Group - Key offerings
  • SWOT
• 15.15 Proteo Genix
  • Proteo Genix - Overview
  • Proteo Genix - Product / Service
  • Proteo Genix - Key offerings
  • SWOT
• 15.16 RS Synthesis
  • RS Synthesis - Overview
  • RS Synthesis - Product / Service
  • RS Synthesis - Key offerings
  • SWOT
• 15.17 Sigma Aldrich Chemicals Ltd.
  • Sigma Aldrich Chemicals Ltd. - Overview
  • Sigma Aldrich Chemicals Ltd. - Product / Service
  • Sigma Aldrich Chemicals Ltd. - Key offerings
  • SWOT
• 15.18 Thermo Fisher Scientific Inc.
  • Thermo Fisher Scientific Inc. - Overview
  • Thermo Fisher Scientific Inc. - Business segments
  • Thermo Fisher Scientific Inc. - Key news
  • Thermo Fisher Scientific Inc. - Key offerings
  • Thermo Fisher Scientific Inc. - Segment focus
  • SWOT

16 Appendix

• 16.1 Scope of the report
  • Market definition
  • Objectives
  • Notes and caveats
• 16.2 Inclusions and exclusions checklist
  • Inclusions checklist
  • Exclusions checklist
• 16.3 Currency conversion rates for US$
  • Currency conversion rates for US$
• 16.4 Research methodology
  • Research methodology
• 16.5 Data procurement
  • Information sources
• 16.6 Data validation
  • Data validation
• 16.7 Validation techniques employed for market sizing
  • Validation techniques employed for market sizing
• 16.8 Data synthesis
  • Data synthesis
• 16.9 360 degree market analysis
  • 360 degree market analysis
• 16.10 List of abbreviations
  • List of abbreviations